730 related articles for article (PubMed ID: 33578036)
1. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
Azad T; Singaravelu R; Taha Z; Jamieson TR; Boulton S; Crupi MJF; Martin NT; Fekete EEF; Poutou J; Ghahremani M; Pelin A; Nouri K; Rezaei R; Marshall CB; Enomoto M; Arulanandam R; Alluqmani N; Samson R; Gingras AC; Cameron DW; Greer PA; Ilkow CS; Diallo JS; Bell JC
Mol Ther; 2021 Jun; 29(6):1984-2000. PubMed ID: 33578036
[TBL] [Abstract][Full Text] [Related]
2. ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants.
Ou J; Zhang Y; Wang Y; Zhang Z; Wei H; Yu J; Wang Q; Wang G; Zhang B; Wang C
Signal Transduct Target Ther; 2022 Feb; 7(1):43. PubMed ID: 35140198
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition.
Azad T; Singaravelu R; Fekete EEF; Taha Z; Rezaei R; Arulanandam R; Boulton S; Diallo JS; Ilkow CS; Bell JC
Biosens Bioelectron; 2021 May; 180():113122. PubMed ID: 33706157
[TBL] [Abstract][Full Text] [Related]
4. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
Brown EEF; Rezaei R; Jamieson TR; Dave J; Martin NT; Singaravelu R; Crupi MJF; Boulton S; Tucker S; Duong J; Poutou J; Pelin A; Yasavoli-Sharahi H; Taha Z; Arulanandam R; Surendran A; Ghahremani M; Austin B; Matar C; Diallo JS; Bell JC; Ilkow CS; Azad T
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668756
[TBL] [Abstract][Full Text] [Related]
6. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment.
Malladi SK; Singh R; Pandey S; Gayathri S; Kanjo K; Ahmed S; Khan MS; Kalita P; Girish N; Upadhyaya A; Reddy P; Pramanick I; Bhasin M; Mani S; Bhattacharyya S; Joseph J; Thankamani K; Raj VS; Dutta S; Singh R; Nadig G; Varadarajan R
J Biol Chem; 2021; 296():100025. PubMed ID: 33154165
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
Elife; 2020 Oct; 9():. PubMed ID: 33103998
[TBL] [Abstract][Full Text] [Related]
8. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470
[TBL] [Abstract][Full Text] [Related]
9. Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein.
Shi Y; Zeida A; Edwards CE; Mallory ML; Sastre S; Machado MR; Pickles RJ; Fu L; Liu K; Yang J; Baric RS; Boucher RC; Radi R; Carroll KS
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35074895
[TBL] [Abstract][Full Text] [Related]
10. N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6.
Das T; Luo S; Tang H; Fang J; Mao Y; Yen HH; Dash S; Shajahan A; Pepi L; Huang S; Jones VS; Xie S; Huang GF; Lu J; Anderson B; Zhang B; Azadi P; Huang RP
Microbiol Immunol; 2024 May; 68(5):165-178. PubMed ID: 38444370
[TBL] [Abstract][Full Text] [Related]
11. Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding.
Lin S; Chen Z; Zhang X; Wen A; Yuan X; Yu C; Yang J; He B; Cao Y; Lu G
Signal Transduct Target Ther; 2022 Feb; 7(1):56. PubMed ID: 35190526
[No Abstract] [Full Text] [Related]
12. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
13. Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies.
Yuan M; Liu H; Wu NC; Wilson IA
Biochem Biophys Res Commun; 2021 Jan; 538():192-203. PubMed ID: 33069360
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
15. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach.
Kwarteng A; Asiedu E; Sylverken AA; Larbi A; Sakyi SA; Asiedu SO
Infect Genet Evol; 2021 Jul; 91():104815. PubMed ID: 33774178
[TBL] [Abstract][Full Text] [Related]
17. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
[TBL] [Abstract][Full Text] [Related]
18. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response.
Liu Z; Xu W; Xia S; Gu C; Wang X; Wang Q; Zhou J; Wu Y; Cai X; Qu D; Ying T; Xie Y; Lu L; Yuan Z; Jiang S
Signal Transduct Target Ther; 2020 Nov; 5(1):282. PubMed ID: 33247109
[TBL] [Abstract][Full Text] [Related]
19. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.
Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells.
Zheng L; Ma Y; Chen M; Wu G; Yan C; Zhang XE
Biochem Biophys Res Commun; 2021 Nov; 579():69-75. PubMed ID: 34592572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
